Literature DB >> 27815306

Cellular Models for the Study of Prions.

Brandon B Holmes1,2, Marc I Diamond2.   

Abstract

It is now established that numerous amyloid proteins associated with neurodegenerative diseases, including tau and α-synuclein, have essential characteristics of prions, including the ability to create transmissible cellular pathology in vivo. We have developed cellular bioassays that report on the various features of prion activity using genetic engineering and quantitative fluorescence-based detection systems. We have exploited these biosensors to measure the binding and uptake of tau seeds into cells in culture and to quantify seeding activity in brain samples. These cell models have also been used to propagate tau prion strains indefinitely in culture. In this review, we illustrate the utility of cellular biosensors to gain mechanistic insight into prion transmission and to study neurodegenerative diseases in a reductionist fashion.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27815306      PMCID: PMC5287063          DOI: 10.1101/cshperspect.a024026

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  8 in total

Review 1.  Bioassays and Inactivation of Prions.

Authors:  Kurt Giles; Amanda L Woerman; David B Berry; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 2.  α-Synuclein: Multiple System Atrophy Prions.

Authors:  Amanda L Woerman; Joel C Watts; Atsushi Aoyagi; Kurt Giles; Lefkos T Middleton; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

Review 3.  Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.

Authors:  Jennifer N Rauch; Steven H Olson; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

Review 4.  Cellular models of alpha-synuclein toxicity and aggregation.

Authors:  Marion Delenclos; Jeremy D Burgess; Agaristi Lamprokostopoulou; Tiago F Outeiro; Kostas Vekrellis; Pamela J McLean
Journal:  J Neurochem       Date:  2019-07-30       Impact factor: 5.372

Review 5.  Seeking a New Paradigm for Alzheimer's Disease: Considering the Roles of Inflammation, Blood-Brain Barrier Dysfunction, and Prion Disease.

Authors:  Mark E McCaulley; Kira A Grush
Journal:  Int J Alzheimers Dis       Date:  2017-12-05

Review 6.  The Prion-Like Behavior of Assembled Tau in Transgenic Mice.

Authors:  Florence Clavaguera; Markus Tolnay; Michel Goedert
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

7.  FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments.

Authors:  Senthilvelrajan Kaniyappan; Katharina Tepper; Jacek Biernat; Ram Reddy Chandupatla; Sabrina Hübschmann; Stephan Irsen; Sandra Bicher; Christoph Klatt; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

Review 8.  Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns.

Authors:  David M Asher; Ermias Belay; Eileen Bigio; Sebastian Brandner; Scott A Brubaker; Byron Caughey; Brychan Clark; Inger Damon; Marc Diamond; Michelle Freund; Bradley T Hyman; Mathias Jucker; C Dirk Keene; Andrew P Lieberman; Miroslaw Mackiewicz; Thomas J Montine; Susan Morgello; Creighton Phelps; Jiri Safar; Julie A Schneider; Lawrence B Schonberger; Christina Sigurdson; Nina Silverberg; John Q Trojanowski; Matthew P Frosch
Journal:  J Neuropathol Exp Neurol       Date:  2020-11-01       Impact factor: 3.148

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.